Literature DB >> 16157837

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.

Elizabeth Selvin1, Josef Coresh, Sherita H Golden, Frederick L Brancati, Aaron R Folsom, Michael W Steffes.   

Abstract

BACKGROUND: Chronic hyperglycemia has been hypothesized to contribute to coronary heart disease (CHD), but the extent to which hemoglobin A(1c) (HbA(1c)) level, a marker of long-term glycemic control, is independently related to CHD risk is uncertain.
METHODS: We conducted a prospective case-cohort study of 1321 adults without diabetes and a cohort study of 1626 adults with diabetes from the Atherosclerosis Risk in Communities Study. Using proportional hazards models, we assessed the relation between HbA(1c) level and incident CHD during 8 to 10 years of follow-up.
RESULTS: In adults with diabetes, the relative risk (RR) of CHD was 2.37 (95% confidence interval [CI], 1.50-3.72) for the highest quintile of HbA(1c) level compared with the lowest after adjustment for CHD risk factors. In persons without diabetes, the adjusted RR of CHD in the highest quintile of HbA(1c) level was 1.41 (95% CI, 0.90-2.30); however, there was evidence of a nonlinear relationship in this group. In nondiabetic adults, HbA(1c) level was not related to CHD risk below a level of 4.6% but was significantly related to risk above that level (P<.001). In diabetic adults, the risk of CHD increased throughout the range of HbA(1c) levels. In the adjusted model, the RR of CHD for a 1-percentage point increase in HbA(1c) level was 2.36 (95% CI, 1.43-3.90) in persons without diabetes but with an HbA(1c) level greater than 4.6%. In diabetic adults, the RR was 1.14 (95% CI, 1.07-1.21) per 1-percentage point increase in HbA(1c) across the full range of HbA(1c) values.
CONCLUSION: Elevated HbA(1c) level is an independent risk factor for CHD in persons with and without diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157837     DOI: 10.1001/archinte.165.16.1910

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  82 in total

1.  Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes.

Authors:  April P Carson; Caroline S Fox; Darren K McGuire; Emily B Levitan; Martin Laclaustra; Devin M Mann; Paul Muntner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-05

2.  Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?

Authors:  H C Gerstein
Journal:  Diabetologia       Date:  2010-11-20       Impact factor: 10.122

3.  Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.

Authors:  C-L Huang; H-W Chang; J-B Chang; J-H Chen; J-D Lin; C-Z Wu; D Pei; Y-J Hung; C-H Lee; Y-L Chen; C-H Hsieh
Journal:  QJM       Date:  2015-11-16

4.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

5.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

6.  Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study.

Authors:  Amy B Kauffman; Thomas Delate; Kari L Olson; Alicia A Cymbala; Kara A Hutka; Sheila L Kasten; Jon R Rasmussen
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 7.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 8.  Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.

Authors:  Elizabeth Selvin; Shari Bolen; Hsin-Chieh Yeh; Crystal Wiley; Lisa M Wilson; Spyridon S Marinopoulos; Leonard Feldman; Jason Vassy; Renee Wilson; Eric B Bass; Frederick L Brancati
Journal:  Arch Intern Med       Date:  2008-10-27

Review 9.  Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Authors:  Hertzel C Gerstein
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

Review 10.  Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement.

Authors:  Saifullah Nasir; David Aguilar
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.